Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
This study is looking at whether 1 can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.
This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
This study is looking at whether Randomised trial with three groups: 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Randomised trial with three groups: 1 and complete follow-up assessments.
This study is looking at care and outcomes for people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.
This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.
This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.
This study is looking at whether 1 can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.
This study is looking at how 7 - 12 intervention treatment sessions from a research psychologist plus routine care versus routine care only works for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia in routine care. Participants take part in 7 - 12 intervention treatment sessions from a research psychologist plus routine care versus routine care only and complete follow-up assessments.
This study is looking at whether questionnaires and follow-up can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Mental disorder, not otherwise specified. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in 1 and complete follow-up assessments.
This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Mental disorder, not otherwise specified. Participants take part in 1 and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Scizophrenia. Direct benefit is not guaranteed, but the study may help researchers improve future care.
This study is looking at care and outcomes for people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Patients will receive 8 sessions of either adherence therapy or health education delivered by a trained therapist in each of the five sites can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether A three-arm double blind parallel design trial of placebo, haloperidol and risperidone can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether 1 can help people with Mental Disorders, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Four groups were randomly allocated to placebo or 1 g, 2 g or 4 g ethyl-EPA/day on a double blind basis can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.